| The endocannabinoid system as an emerging target of pharmacotherapy P Pacher, S Bátkai, G Kunos Pharmacological reviews 58 (3), 389-462, 2006 | 2660 | 2006 |
| International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2 RG Pertwee, AC Howlett, ME Abood, SPH Alexander, V Di Marzo, ... Pharmacological reviews 62 (4), 588-631, 2010 | 2026 | 2010 |
| Leptin-regulated endocannabinoids are involved in maintaining food intake V Di Marzo, SK Goparaju, L Wang, J Liu, S Bátkai, Z Járai, F Fezza, ... Nature 410 (6830), 822-825, 2001 | 2010 | 2001 |
| Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity D Osei-Hyiaman, M DePetrillo, P Pacher, J Liu, S Radaeva, S Bátkai, ... The Journal of clinical investigation 115 (5), 1298-1305, 2005 | 1355 | 2005 |
| Nonpsychotropic cannabinoid receptors regulate microglial cell migration L Walter, A Franklin, A Witting, C Wade, Y Xie, G Kunos, K Mackie, ... Journal of Neuroscience 23 (4), 1398-1405, 2003 | 805 | 2003 |
| Endocannabinoid signaling at the periphery: 50 years after THC M Maccarrone, I Bab, T Bíró, GA Cabral, SK Dey, V Di Marzo, JC Konje, ... Trends in pharmacological sciences 36 (5), 277-296, 2015 | 773 | 2015 |
| Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Z Járai, JA Wagner, K Varga, KD Lake, DR Compton, BR Martin, ... Proceedings of the National Academy of Sciences 96 (24), 14136-14141, 1999 | 737 | 1999 |
| Presynaptic specificity of endocannabinoid signaling in the hippocampus RI Wilson, G Kunos, RA Nicoll Neuron 31 (3), 453-462, 2001 | 659 | 2001 |
| Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors N Agarwal, P Pacher, I Tegeder, F Amaya, CE Constantin, GJ Brenner, ... Nature neuroscience 10 (7), 870-879, 2007 | 656 | 2007 |
| A biosynthetic pathway for anandamide J Liu, L Wang, J Harvey-White, D Osei-Hyiaman, R Razdan, Q Gong, ... Proceedings of the National Academy of Sciences 103 (36), 13345-13350, 2006 | 568 | 2006 |
| Evidence for novel cannabinoid receptors M Begg, P Pacher, S Bátkai, D Osei-Hyiaman, L Offertáler, FM Mo, J Liu, ... Pharmacology & therapeutics 106 (2), 133-145, 2005 | 538 | 2005 |
| Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity J Tam, VK Vemuri, J Liu, S Bátkai, B Mukhopadhyay, G Godlewski, ... The Journal of clinical investigation 120 (8), 2953-2966, 2010 | 523 | 2010 |
| Platelet‐and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotension K Varga, JA Wagner, DT Bridgen, G Kunos The FASEB journal 12 (11), 1035-1044, 1998 | 522 | 1998 |
| Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice D Osei-Hyiaman, J Liu, L Zhou, G Godlewski, J Harvey-White, W Jeong, ... The Journal of clinical investigation 118 (9), 3160-3169, 2008 | 508 | 2008 |
| Modulating the endocannabinoid system in human health and disease–successes and failures P Pacher, G Kunos The FEBS journal 280 (9), 1918-1943, 2013 | 484 | 2013 |
| Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves EJN Ishac, L Jiang, KD Lake, K Varga, ME Abood, G Kunos British journal of pharmacology 118 (8), 2023-2028, 1996 | 468 | 1996 |
| Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis S Bátkai, Z Járai, JA Wagner, SK Goparaju, KÁ Varga, J Liu, L Wang, ... Nature medicine 7 (7), 827-832, 2001 | 466 | 2001 |
| Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly P Pacher, S Steffens, G Haskó, TH Schindler, G Kunos Nature Reviews Cardiology 15 (3), 151-166, 2018 | 408 | 2018 |
| Functional CB1 cannabinoid receptors in human vascular endothelial cells J LIU, B GAO, F MIRSHAHI, AJ SANYAL, AD KHANOLKAR, ... Biochemical Journal 346 (3), 835-840, 2000 | 408 | 2000 |
| Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes T Jourdan, G Godlewski, R Cinar, A Bertola, G Szanda, J Liu, J Tam, ... Nature medicine 19 (9), 1132-1140, 2013 | 400 | 2013 |
Resat CinarNational Institute on Alcohol Abuse and Alcoholism / National Institutes of Health在 nih.gov 的电子邮件经过验证
